Adam S. Grossman Sells 100,000 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) Stock

ADMA Biologics, Inc. (NASDAQ:ADMA – Get Free Report) CEO Adam S. Grossman sold 100,000 shares of the firm’s stock in a transaction dated Friday, June 14th. The shares were sold at an average price of $10.72, for a total value of $1,072,000.00. Following the sale, the chief executive officer now owns 2,081,475 shares of the […]

Related Keywords

United States ,Raymond James ,Adams Grossman ,Biologics Company Profile ,Caxton Associates ,Pricet Rowe Associates Inc ,Nasdaq ,Lazard Asset Management ,Securities Exchange Commission ,Adma Biologics Inc ,Castleark Management ,Cantor Fitzgerald ,Bellevue Group ,Biologics Inc ,Get Free Report ,Exchange Commission ,Asset Management ,